Nicole Marten
Overview
Explore the profile of Nicole Marten including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
2283
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Goligher E, Bradbury C, McVerry B, Lawler P, Berger J, Gong M, et al.
N Engl J Med
. 2021 Aug;
385(9):777-789.
PMID: 34351722
Background: Thrombosis and inflammation may contribute to morbidity and mortality among patients with coronavirus disease 2019 (Covid-19). We hypothesized that therapeutic-dose anticoagulation would improve outcomes in critically ill patients with...
2.
Lawler P, Goligher E, Berger J, Neal M, McVerry B, Nicolau J, et al.
N Engl J Med
. 2021 Aug;
385(9):790-802.
PMID: 34351721
Background: Thrombosis and inflammation may contribute to the risk of death and complications among patients with coronavirus disease 2019 (Covid-19). We hypothesized that therapeutic-dose anticoagulation may improve outcomes in noncritically...
3.
Lofgren S, Nicol M, Bangdiwala A, Pastick K, Okafor E, Skipper C, et al.
Open Forum Infect Dis
. 2020 Nov;
7(11):ofaa500.
PMID: 33204764
Background: Use of hydroxychloroquine in hospitalized patients with coronavirus disease 2019 (COVID-19), especially in combination with azithromycin, has raised safety concerns. Here, we report safety data from 3 outpatient randomized...
4.
Angus D, Buzgau A, Cheng A, Higgins A, Hullegie S, Lawler P, et al.
JAMA
. 2020 Sep;
324(13):1317-1329.
PMID: 32876697
Importance: Evidence regarding corticosteroid use for severe coronavirus disease 2019 (COVID-19) is limited. Objective: To determine whether hydrocortisone improves outcome for patients with severe COVID-19. Design, Setting, And Participants: An...
5.
Lofgren S, Nicol M, Bangdiwala A, Pastick K, Okafor E, Skipper C, et al.
medRxiv
. 2020 Aug;
PMID: 32743591
Introduction: Use of hydroxychloroquine in hospitalized patients with COVID-19, especially in combination with azithromycin, has raised safety concerns. Here, we report safety data from three outpatient randomized clinical trials. Methods:...
6.
Boulware D, Pullen M, Bangdiwala A, Pastick K, Lofgren S, Okafor E, et al.
N Engl J Med
. 2020 Jun;
383(6):517-525.
PMID: 32492293
Background: Coronavirus disease 2019 (Covid-19) occurs after exposure to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). For persons who are exposed, the standard of care is observation and quarantine. Whether...
7.
Lother S, Abassi M, Agostinis A, Bangdiwala A, Cheng M, Drobot G, et al.
Can J Anaesth
. 2020 May;
67(9):1201-1211.
PMID: 32383125
Background: The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in December 2019 causing the coronavirus disease (COVID-19) pandemic. Currently, there is a lack of evidence-based therapies to prevent COVID-19...
8.
Kredentser M, Blouw M, Marten N, Sareen J, Bienvenu O, Ryu J, et al.
Crit Care Med
. 2018 Aug;
46(12):1914-1922.
PMID: 30119073
Objectives: Critical illness can have a significant psychological impact on patients and their families. To inform the design of a larger trial, we assessed feasibility of ICU diaries and psychoeducation...
9.
Fowler R, Rishu A, Marinoff N, Julien L, Dumitrascu M, Marten N, et al.
J Crit Care
. 2017 Apr;
40:272.
PMID: 28390754
No abstract available.
10.
Rishu A, Marinoff N, Julien L, Dumitrascu M, Marten N, Eggertson S, et al.
J Crit Care
. 2017 Mar;
40:7-10.
PMID: 28288355
Purpose: Observational research focused upon emerging infectious diseases such as Ebola virus, Middle East respiratory syndrome, and Zika virus has been challenging to quickly initiate. We aimed to determine the...